Back to Journals » Vascular Health and Risk Management » Volume 14

Antihypertensive effect of the mineralocorticoid receptor antagonist eplerenone: a pooled analysis of patient-level data from comparative trials using regulatory-approved doses

Total article views   Abstract views HTML views PDF downloads Totals
6,040 Dovepress* 4,664 832+ 1,076 5,496
PubMed Central* 0 544 148 544
Totals 4,664 1,376 1,224 6,040
*Since 20 September 2018
+Since July 2016

View citations on PubMed Central and Google Scholar